Skip to main content
Signal8

Renalytix plc (RNLXY)

Sector: Services-Medical Laboratories

RNLXY logo

OTC:RNLXY

OTC:RNLXY
+2.70%$3.80
Mkt Cap-
EV-
Float-
O/S-
Inst Own-
Net Cash/Sh-
Dilution
Pipeline4 lead-sponsored trials·4 active0 completed

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Status
  • Observational
    Active, not recruiting

    Decision Impact Trial of KidneyIntelX

    KidneyIntelX

    Diabetic Kidney Disease

    Enrollment
    1,500
    Start
    Nov 2021
    Primary Completion
    Nov 2026est.
    Completion
    Dec 2026est.
    NCT04791358
  • Observational
    Recruiting

    Real World Evidence Clinical Utility Study of KidneyIntelX

    KidneyIntelX

    Chronic Kidney Diseases, Diabetic Kidney Disease

    Enrollment
    10,000
    Start
    Mar 2021
    Primary Completion
    Dec 2026est.
    Completion
    Dec 2026est.
    NCT04802395
  • Observational
    Active, not recruiting

    Prospective Decision Impact Trial of KidneyIntelX

    KidneyIntelX

    Diabetic Kidney Disease, Chronic Kidney Disease Stage 1 +2

    Enrollment
    2,000
    Start
    Nov 2021
    Primary Completion
    Dec 2023
    Completion
    Dec 2026est.
    NCT04960514
  • Observational
    Active, not recruiting

    Prospective Decision Impact Clinical Utility Trial of KidneyIntelX

    KidneyIntelX

    Diabetic Kidney Disease, Chronic Kidney Diseases +3

    Enrollment
    2,000
    Start
    Nov 2021
    Primary Completion
    Dec 2023
    Completion
    Nov 2026est.
    NCT05198284